Press release
Angiotensin II Receptor Blockers Market Growth Drivers and Distribution Channels Forecast to 2024-2031 - Novartis AG, Daiichi Sankyo Co. Ltd, Lupin Ltd.
Angiotensin II Receptor Blockers Market is valued at a significant CAGR during the forecast period (2024-2031).Angiotensin II Receptor Blockers Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/angiotensin-ii-receptor-blockers-market?rk
Angiotensin II Receptor Blockers are medications used to manage high blood pressure, heart failure, and kidney diseases. ARBs work by blocking the action of angiotensin II, a hormone that narrows blood vessels, resulting in improved blood flow and reduced pressure. These medications are often prescribed to patients who cannot tolerate ACE inhibitors. ARBs are known to lower cardiovascular risks and protect kidney function in diabetic patients. Regular monitoring and dosage adjustments help maximize their effectiveness.
List of the Key Players in the Angiotensin II Receptor Blockers Market:
Novartis AG, Daiichi Sankyo Co. Ltd, Lupin Ltd, Novartis AG, Takeda Pharmaceutical Co. Ltd, AstraZeneca, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim, Abbive Inc, Zydus Cadila.
Industry Development:
On March 26, 2024, Otsuka Pharmaceutical Co., Ltd. announced that Novartis Pharma K.K. has obtained approval for Entresto Granular Tablets for Pediatric Use (12.5 mg / 31.25 mg), containing the active ingredient sacubitril valsartan sodium hydrate. These tablets are classified as an angiotensin receptor neprilysin inhibitor (ARNI).
Growth Forecast Projected:
The Global Angiotensin II Receptor Blockers Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Angiotensin II Receptor Blockers Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/angiotensin-ii-receptor-blockers-market?rk
Segment Covered in the Angiotensin II Receptor Blockers Market:
By Type: Valsartan, Azilsartan, Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Others.
By Application: Heart Failure, Hypertension, Kidney Disease, Others.
By End-Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other.
Regional Analysis for Angiotensin II Receptor Blockers Market:
The regional analysis of the Angiotensin II Receptor Blockers Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/angiotensin-ii-receptor-blockers-market?rk
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Angiotensin II Receptor Blockers market?
➠ Who are the leading manufacturers in the global Angiotensin II Receptor Blockers industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Angiotensin II Receptor Blockers industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Angiotensin II Receptor Blockers market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Browse More Reports: https://www.datamintelligence.com/research-report/angiotensin-ii-receptor-blockers-market?rk
Related Reports
Chronic Kidney Disease Drugs Market: https://datamintelligence.com/research-report/chronic-kidney-disease-drugs-market?rk
Anti-Hypertension Drugs Market: https://datamintelligence.com/research-report/anti-hypertension-drugs-market?rk
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin II Receptor Blockers Market Growth Drivers and Distribution Channels Forecast to 2024-2031 - Novartis AG, Daiichi Sankyo Co. Ltd, Lupin Ltd. here
News-ID: 3906837 • Views: …
More Releases from DataM Intelligence 4market Research LLP

Future of RNAi Therapeutics: Small Interfering RNAs, MicroRNAs, and Targeted Tre …
The Global RNAi Therapeutics Market is estimated to reach at a high CAGR 17.4% during the forecast period (2024-2031).
The RNAi therapeutics market includes drugs that use RNA interference mechanisms to silence specific genes responsible for disease. These therapies offer precision treatment options for cancers, viral infections, and genetic disorders. Market growth is driven by increasing investment in biotechnology, rising prevalence of target diseases, and clinical trial advancements. Delivery systems such…

United States Natural Fiber Composite Market Outlook 2024-2031: Sustainable Mate …
Global Natural Fiber Composite Market reached US$ 327.0 Million in 2023 and is expected to reach US$ 494.3 Million by 2031, growing with a CAGR of 5.3% during the forecast period 2024-2031.
The natural fiber composite market focuses on materials made by combining natural fibers such as jute, flax, hemp, or sisal with polymer matrices. These composites are used in automotive, construction, packaging, and consumer goods for lightweight, sustainable, and eco-friendly…

United States Electrochemical Sensors Market Growth Outlook: Nanomaterials, Wire …
The Electrochemical Sensors Market is valued at a significant CAGR during the forecast period (2024-2031).
The electrochemical sensors market covers devices that detect chemical species using electrochemical reactions to generate measurable signals. Applications include healthcare diagnostics, environmental monitoring, food safety, and industrial process control. Market growth is driven by demand for point-of-care testing, wearable devices, and real-time monitoring. Advances in miniaturization, nanomaterials, and wireless connectivity enhance sensor performance. Integration with IoT…

United States Bauxite Market Outlook 2024-2031: Rising Aluminum Demand and Indus …
Global Bauxite Market reached US$ 14.8 billion in 2022 and is expected to reach US$ 19.7 billion by 2031, growing with a CAGR of 3.7% during the forecast period 2024-2031.
The bauxite market involves the mining and processing of bauxite ore, the primary raw material for aluminum production. It is also used in refractory materials, abrasives, and chemicals. Market growth is driven by increasing aluminum demand in automotive, aerospace, and packaging…
More Releases for Angiotensin
Innovative Product Solution In The Angiotensin Receptor Blockers Market Industry …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Angiotensin Receptor Blockers (ARBs) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Growth has been consistently noted in the angiotensin receptor blockers (arbs) market size in the past few years. The market will see an increase from $8.51 billion in 2024 to $8.78 billion in…
Angiotensin Converting Enzyme (ACE) Inhibitors Market
Angiotensin Converting Enzyme (ACE) inhibitors are a class of pharmaceutical drugs used primarily for the treatment of high blood pressure (hypertension), heart failure, and chronic kidney diseases. These medications help to relax blood vessels, thereby lowering blood pressure and improving heart function. ACE inhibitors block the activity of the enzyme that converts angiotensin I to angiotensin II, a peptide that narrows blood vessels. By inhibiting this conversion, ACE inhibitors enable…
Angiotensin Converting Enzyme (ACE) Inhibitors Market: An Overview
Angiotensin Converting Enzyme (ACE) inhibitors are a class of medications widely used in the treatment of various cardiovascular conditions, primarily high blood pressure (hypertension) and heart failure. These drugs work by blocking the action of the enzyme angiotensin-converting enzyme, which is responsible for producing a substance called angiotensin II. Angiotensin II constricts blood vessels and raises blood pressure. By inhibiting this enzyme, ACE inhibitors help relax blood vessels, lower blood…
Prominent Angiotensin Receptor Blockers (ARBs) Market Trend for 2025: Innovative …
What market dynamics are playing a key role in accelerating the growth of the angiotensin receptor blockers (arbs) market?
The upward trend of cardiovascular diseases is predicted to fuel advancements in the angiotensin receptor blockers market. Often related to the accumulation of fatty components within the arteries (atherosclerosis) and heightened probability of blood clots, cardiovascular disease (CVD) influences the heart or blood vessels. The function of angiotensin receptor blockers is to…
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…